Denis Chem Lab

Denis Chem Lab Gross Margin

The Gross Margin of Denis Chem Lab (537536.BO) as of Oct 21, 2026 is 44.92 %. In the previous year, Gross Margin was 38.99 % — a change of 15.20% (higher).

Gross Margin

44.92 %

YoY

15.20%

Last updated:

Gross Margin of Denis Chem Lab is 2025 44.92 % . Gross Margin of Denis Chem Lab was 2024 38.99 % . It decreases by 15.20% higher compared to the previous year.

For Denis Chem Lab, the gross margin of 44.9% is down versus 47.0% a few years ago.

The Denis Chem Lab Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
50.26 INR
Jan 1, 2019
54.78 INR
Jan 1, 2020
49.29 INR
Jan 1, 2021
47.02 INR
Jan 1, 2022
47.49 INR
Jan 1, 2023
48.24 INR
Jan 1, 2024
38.99 INR
Jan 1, 2025
44.92 INR
The Denis Chem Lab Gross Margin history
YEARGross MarginYoY
44.92 %+15.20%
38.99 %-19.18%
48.24 %+1.58%
47.49 %+1.00%
47.02 %-4.60%
49.29 %-10.02%
54.78 %+8.99%
50.26 %-5.80%
53.36 %+6.05%
50.31 %+36.15%
36.95 %+6.34%
34.75 %+10,218.09%
0.34 %+8.78%
0.31 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Denis Chem Lab Stock analysis

What does Denis Chem Lab do? Denis Chem Lab Ltd. generates revenue through the manufacture and sale of transfusion solutions in bottles, including sterile intravenous injectables for human and veterinary use. The company offers a range of products such as carbohydrate solutions, sodium chloride solutions, potassium chloride solutions, and plasma volume expanders under its own brands. It also produces sterile intravenous injectables in volumes from 100 milliliters to 10 liters for direct sales to customers. Additionally, the firm manufactures contract products for multinational pharmaceutical companies, leveraging its facility for third-party production. The company's primary customers include healthcare providers and veterinary institutions that require sterile intravenous solutions. Its product portfolio targets both human and veterinary markets, with offerings like antibiotic solutions and dialysis solutions catering to specific medical needs. The firm's contract manufacturing services provide an additional revenue stream by supplying multinational pharmaceutical companies with custom-produced sterile injectables. Denis Chem Lab Ltd. focuses on manufacturing and selling its own branded products, such as carbohydrate in sodium chloride solutions and multi electrolyte solutions, while also engaging in contract manufacturing for multinational pharmaceutical companies. The company's production capabilities span from small-volume solutions to large 10-liter bottles, ensuring versatility in meeting diverse customer demands across healthcare and veterinary sectors. Denis Chem Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Denis Chem Lab stock

Gross Margin of Denis Chem Lab is 44.92 % in 2025.

Gross Margin of Denis Chem Lab changed from 38.99 % to 44.92 %, representing a 15.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Denis Chem Lab since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Denis Chem Lab with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Denis Chem Lab

All Key Metrics — Denis Chem Lab